Task: Answer the MCQ question.
Query: Which drug exhibits a 22.202% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) Oc1ccc(N2CCN(Cc3cc4c(cc3Br)OCCO4)CC2)cc1
b.) Cn1c(SCC(=O)N2CCCCC2)nc2cccnc21
c.) Cc1cc(=O)oc2c(C)c(OC(C)C(=O)NCC3CCC(C(=O)O)CC3)ccc12
Answer: b. Cn1c(SCC(=O)N2CCCCC2)nc2cccnc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(SCC(=O)N2CCCCC2)nc2cccnc21
Cn1c(SCC(=O)N2CCCCC2)nc2cccnc21
2-(3-methylimidazo[4,5-b]pyridin-2-yl)sulfanyl-1-piperidin-1-ylethanone